Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by gamma/delta T cells

BMC Immunology

Volumn 13, Issue , 2012, Pages

  Wozniak, Karen L ^a   Kolls, Jay K ^b   Wormley Jr, Floyd L ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Cryptococcus neoformans; Gamma delta T cells; IL 17A; Pulmonary

Indexed keywords

CXCL1 CHEMOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 21; INTERLEUKIN 23; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POPULATION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; GAMMA DELTA T LYMPHOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; PULMONARY CRYPTOCOCCOSIS;

ANIMALS; CHEMOKINES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; FEMALE; INTERLEUKIN-17; INTRACELLULAR SPACE; LUNG; LUNG DISEASES, FUNGAL; MICE; MICE, INBRED BALB C; NEUTROPHILS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84870499331     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-13-65     Document Type: Article

References (55)

1. Levitz SM. The ecology of cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991, 13:1163-1169. 10.1093/clinids/13.6.1163, 1775849.
2. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995, 8:515-548. 172874, 8665468.
3. Shoham S, Levitz SM. The immune response to fungal infections. Br J Haematol 2005, 129:569-582. 10.1111/j.1365-2141.2005.05397.x, 15916679.
4. Singh N, Gayowski T, Wagener MM, Marino IR. Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clin Transplant 1997, 11:66-70.
5. Singh N, Dromer F, Perfect JR, Lortholary O. Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis 2008, 47:1321-1327. 10.1086/592690, 2696098, 18840080.
6. Hill JO, Harmsen AG. Intrapulmonary growth and dissemination of an avirulent strain of cryptococcus neoformans in mice depleted of CD4+ or CD8+ T-cells. J Exp Med 1991, 173:755-758. 10.1084/jem.173.3.755, 2118808, 1900084.
7. Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 1994, 55:35-42.
8. Huffnagle GB, Yates JL, Lipscomb MF. Immunity to a pulmonary cryptococcus neoformans infection requires both CD4+ and CD8+ T-cells. J Exp Med 1991, 173:793-800. 10.1084/jem.173.4.793, 2190813, 1672543.
9. Mody CH, Lipscomb MF, Street NE, Toews GB. Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to cryptococcus neoformans. J Immunol 1990, 144:1472-1477.
10. Buchanan KL, Doyle HA. Requirement for CD4+ T lymphocytes in host resistance against cryptococcus neoformans in the central nervous system of immunized mice. Infect Immun 2000, 68:456-462. 10.1128/IAI.68.2.456-462.2000, 97163, 10639404.
11. Wormley FL, Perfect JR, Steele C, Cox GM. Protection against cryptococcosis using a murine interferon-gamma producing cryptococcus neoformans strain. Infect Immun 2007, 75:1453-1462. 10.1128/IAI.00274-06, 1828544, 17210668.
12. Wozniak KL, Ravi S, Macias S, Young ML, Olszewski MA, Steele C, Wormley FL. Insights into the mechanisms of protective immunity against cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS One 2009, 4:e6854. 10.1371/journal.pone.0006854, 2731172, 19727388.
13. Young M, Macias S, Thomas D, Wormley FL. A proteomic-based approach for the identification of immunodominant cryptococcus neoformans proteins. Proteomics 2009, 9:2578-2588. 10.1002/pmic.200800713, 2754056, 19343717.
14. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009, 206:299-311. 10.1084/jem.20081463, 2646568, 19204111.
15. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-candida albicans host defense in mice. J Infect Dis 2004, 190:624-631. 10.1086/422329, 15243941.
16. Rudner XL, Happel KI, Young EA, Shellito JE. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine pneumocystis carinii infection. Infect Immun 2007, 75:3055-3061. 10.1128/IAI.01329-06, 1932856, 17403873.
17. Wuthrich M, Gern B, Hung CY, Ersland K, Rocco N, Pick-Jacobs J, Galles K, Filutowicz H, Warner T, Evans M, et al. Vaccine-induced protection against 3 systemic mycoses endemic to north america requires Th17 cells in mice. J Clin Invest 2011, 121:554-568. 10.1172/JCI43984, 3026727, 21206087.
18. Loures FV, Pina A, Felonato M, Calich VL. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol 2009, 183:1279-1290. 10.4049/jimmunol.0801599, 19553529.
19. Voelz K, Lammas DA, May RC. Cytokine signaling regulates the outcome of intracellular macrophage parasitism by cryptococcus neoformans. Infect Immun 2009, 77:3450-3457. 10.1128/IAI.00297-09, 2715691, 19487474.
20. Muller U, Stenzel W, Kohler G, Werner C, Polte T, Hansen G, Schutze N, Straubinger RK, Blessing M, McKenzie ANJ, et al. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with cryptococcus neoformans. J Immunol 2007, 179:5367-5377.
21. Hardison SE, Wozniak KL, Kolls JK, Wormley FL. Interleukin-17 is Not required for classical macrophage activation in a pulmonary mouse model of cryptococcus neoformans infection. Infect Immun 2010, 78:5341-5351. 10.1128/IAI.00845-10, 2981312, 20921149.
22. Zhang Y, Wang F, Tompkins KC, McNamara A, Jain AV, Moore BB, Toews GB, Huffnagle GB, Olszewski MA. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent cryptococcus neoformans H99. Am J Pathol 2009, 175:2489-2500. 10.2353/ajpath.2009.090530, 2789623, 19893050.
23. Wozniak KL, Hardison SE, Kolls JK, Wormley FL. Role of IL-17A on resolution of pulmonary C. Neoformans infection. PLoS One 2011, 6:e17204. 10.1371/journal.pone.0017204, 3040760, 21359196.
24. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003, 170:2106-2112.
25. Werner JL, Gessner MA, Lilly LM, Nelson MP, Metz AE, Horn D, Dunaway CW, Deshane J, Chaplin DD, Weaver CT, et al. Neutrophils produce IL-17A in a Dectin-1 and IL-23 dependent manner during invasive fungal infection. Infect Immun 2011, IAI:05493-05411.
26. Andreasen C, Powell DA, Carbonetti NH. Pertussis toxin stimulates IL-17 production in response to bordetella pertussis infection in mice. PLoS One 2009, 4:e7079. 10.1371/journal.pone.0007079, 2738961, 19759900.
27. Mills KH. Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 2008, 38:2636-2649. 10.1002/eji.200838535, 18958872.
28. Peck A, Mellins ED. Precarious balance: Th17 cells in host defense. Infect Immun 2010, 78:32-38. 10.1128/IAI.00929-09, 2798221, 19901061.
29. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009, 27:485-517. 10.1146/annurev.immunol.021908.132710, 19132915.
30. Ley K, Smith E, Stark MA. IL-17A-producing neutrophil-regulatory Tn lymphocytes. Immunol Res 2006, 34:229-242. 10.1385/IR:34:3:229, 16891673.
31. Smith E, Stark MA, Zarbock A, Burcin TL, Bruce AC, Vaswani D, Foley P, Ley K. IL-17A inhibits the expansion of IL-17A-producing T cells in mice through " short-loop" inhibition via IL-17 receptor. J Immunol 2008, 181:1357-1364. 2586908, 18606690.
32. Song C, Luo L, Lei Z, Li B, Liang Z, Liu G, Li D, Zhang G, Huang B, Feng ZH. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 2008, 181:6117-6124.
33. Kish DD, Li X, Fairchild RL. CD8 T cells producing IL-17 and IFN-gamma initiate the innate immune response required for responses to antigen skin challenge. J Immunol 2009, 182:5949-5959. 10.4049/jimmunol.0802830, 2860745, 19414746.
34. Nembrini C, Marsland BJ, Kopf M. IL-17-producing T cells in lung immunity and inflammation. J Allergy Clin Immunol 2009, 123:986-994. quiz 995-986, 10.1016/j.jaci.2009.03.033, 19410688.
35. Braun RK, Ferrick C, Neubauer P, Sjoding M, Sterner-Kock A, Kock M, Putney L, Ferrick DA, Hyde DM, Love RB. IL-17 producing gammadelta T cells are required for a controlled inflammatory response after bleomycin-induced lung injury. Inflammation 2008, 31:167-179. 10.1007/s10753-008-9062-6, 18338242.
36. Romani L, Zelante T, De Luca A, Fallarino F, Puccetti P. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol 2008, 180:5157-5162.
37. Mednick AJ, Feldmesser M, Rivera J, Casadevall A. Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis. Eur J Immunol 2003, 33:1744-1753. 10.1002/eji.200323626, 12778493.
38. Dejima T, Shibata K, Yamada H, Hara H, Iwakura Y, Naito S, Yoshikai Y. Protective role of naturally occurring interleukin-17A-producing gd T cells in the lung at the early stage of systemic candidiasis in mice. Infect Immun 2011, 79:4503-4510. 10.1128/IAI.05799-11, 3257912, 21875963.
39. Zhang X, Majlessi L, Deriaud E, Leclerc C, Lo-Man R. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity 2009, 31:761-771. 10.1016/j.immuni.2009.09.016, 19913447.
40. Chaturvedi V, Wong B, Newman SL. Oxidative killing of cryptococcus neoformans by human neutrophils - evidence that fungal mannitol protects by scavenging reactive oxygen intermediates. J Immunol 1996, 156:3836-3840.
41. Dong ZM, Murphy JW. Mobility of human neutrophils in response to cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infect Immun 1993, 61:5067-5077. 281285, 8225584.
42. Dong ZM, Murphy JW. Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect Immun 1997, 65:557-563. 176096, 9009313.
43. Mambula SS, Simons ER, Hastey R, Selsted ME, Levitz SM. Human neutrophil-mediated nonoxidative antifungal activity against cryptococcus neoformans. Infect Immun 2000, 68:6257-6264. 10.1128/IAI.68.11.6257-6264.2000, 97707, 11035733.
44. Holtmeier W, Kabelitz D. Gammadelta T cells link innate and adaptive immune responses. Chem Immunol Allergy 2005, 86:151-183.
45. Born WK, Reardon CL, O'Brien RL. The function of gd T cells in innate immunity. Curr Opin Immunol 2006, 18:31-38. 10.1016/j.coi.2005.11.007, 16337364.
46. Wozniak KL, Young ML, Wormley FL. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice. Clin Vacc Immunol 2011, 18:717-723.
47. Gillard GO, Bivas-Benita M, Hovav A-H, Grandpre LE, Panas MW, Seaman MS, Haynes BF, Letvin NL. Thy1+ NK cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes. PLoS Path 2011, 7:e1002141.
48. Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM. Innate invariant NKT cells recognize mycobacterium tuberculosis infected macrophages, produce interferon-g, and kill intracellular bacteria. PLoS Path 2008, 4:e1000239.
49. Coquet JM, Chakravarti S, Kyparissoudis K, McNab FW, Pitt LA, McKenzie BS, Berzins SP, Smyth MJ, Godfrey DI. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc Natl Acad Sci U S A 2008, 105:11287-11292. 10.1073/pnas.0801631105, 2516267, 18685112.
50. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011, 12:21-27.
51. Nishimura H, Yajima T, Kagimoto Y, Ohata M, Watase T, Kishihara K, Goshima F, Nishiyama Y, Yoshikai Y. Intraepithelial gd T cells May bridge a Gap between innate immunity and acquired immunity to herpes simplex virus type 2. J Virol 2004, 78:4927-4930. 10.1128/JVI.78.9.4927-4930.2004, 387699, 15078977.
52. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II, Littman DR, O'Shea JJ. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009, 206:35-41. 10.1084/jem.20072713, 2626689, 19114665.
53. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10:479-489.
54. Milpied P, Massot B, Renand A, Diem S, Herbelin A, Leite-de-Moraes M, Rubio MT, Hermine O. IL-17-producing invariant NKT cells in lymphoid organs are recent thymic emigrants identified by neuropilin-1 expression. Blood 118:2993-3002.
55. Retini C, Vecchiarelli A, Monari C, Tascini C, Bistoni F, Kozel TR. Capsular polysaccharide of cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect Immun 1996, 64:2897-2903. 174164, 8757810.